FDA approves Roche’s HPV self-collection screening option

Betsy Goodfellow | May 15, 2024 | News story | Medical Communications FDA, HPV, Oncology, Roche, cervical cancer 

Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This makes the solution one of the first available in the US, allowing more women to utilise an accessible screening option.

This testing option requires women to collect their own vaginal samples in a healthcare setting, which is then sent to a laboratory for analysis.

Roche has undertaken collaborations with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), on its Cervical Cancer “Last Mile” initiative, which has contributed to the regulatory approval of this novel screening option.

Advertisement

Currently, more than 50% of patients in the US who are diagnosed with cervical cancer have never been screened or have only had infrequent screening and do not participate in routine screening, therefore innovations making screening more accessible are a step in the right direction.

Matt Sause, chief executive officer of Roche Diagnostics, commented: “With vaccinations, innovative diagnostic tools and screening programmes, achieving the World Health Organization’s (WHO) goal of eliminating cervical cancer by 2030 is within reach. Our HPV self-collection solution helps support this goal by reducing barriers and providing access to HPV screening by allowing people to privately collect their own sample for HPV testing.”

Betsy Goodfellow

Related Content

Rethinking oncology trial endpoints with generalised pairwise comparisons

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation

Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) …

FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

The US Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccines, Spikevax and …

The Gateway to Local Adoption Series

Latest content